Charity registration nwnber- 1154727
Exeter Leukaemia Fund CIO
Annual Report and Financial Statements
for the Year Ended 31 March 2024

Exeter Leukaemia Fund CIO
Contents (continued)
Reference and Administrdtive Details
Trustees, Report
2tolO
Statement of Trusiees, Resporksibilitie5
Independent ExamineWs Repon
12
Sialement of Financial Activities
13to 14
Balance Sheet
15
Noies to the Financial Ststements
161027

Exeter Leukaemia Fund CIO
Reference and Administrative Details
Chairman
V E S Salomonsen
Trustees
V E S Salomonsen
l M Kenny
CFOX
J M Hawkins
Sscann
S R Cooper
Senior Management l Leadership M Southwood. Chief Executive OITicer
Team
CharitN Registr9tion Tr*umber
154727
Principal Office
The ELF Offiee
Haematology Centre
RoK'al Devon & Exeter Hospital
Barrack Road
Exeter
EX? 5DW
Independent Exgminer
Thompson Jenner LLP
Indepcndent Examiner
I Colleion Crescent
Exeter
DeN"on
EX? 4DG
Solicitors
Tozers Solicitors LLP
Broadwalk House
Southernhay West
Barclays Bank PLC
3 Bedford Streei
Exeier
Dei'on
Bankers
EXI ILX
Saniander UK PLC
si High Sireel
Exeter
Devon
EX4 3HE
Page I

Exeter Leukaemia Fund CIO
Trustees, Report
The trusiees present the annual report toeether with the financial statements of the charity for the year ended 31
March 2024.
Trustees and officers
The trustees and officers serving during the year and since the year end were as follows=
Trustees-
V E S Salomonsen
l M Kenny
J M Hawkins
Sscann
S R Cooper
Chairman..
V E S Salomonsen
Senior Managemeni l Leadership
Team..
M Southwood. Chief Execulive o￿lcer
S Peacock. Head of Operations and Finance {re5igned 21 June 2024)
Chief Exeeutii'e O￿leer'S Statement
This year. ELF ha5 focused on deli¥erin? hiJo quality, relevant and impaciful patient services. &s well as
continuing to provide support to the NHS Haematology Centre. Our core services include transport lor patients
lo and from appointments. accommodaiion in Exeter for patients receiving reatment at the Royal Devon &
Exerer Hospithl. financial SLEPPOrt and advice. coun5elling and wellbeing supporL complementhry therapies. and
the provision of refreshments ai the Filling Time kiosk on Y3ty' Ward.
A¢r05S the year we 5UPPOrted around ?50 patients and families. representing around a quarter of adult patients
affected by blood cancer in Devon. We have reviewed all of our service5 to ensure ￿'e are operating efficiently
and safely and introduced methods for colleclino
paiieni feedback to infomi the dewelopmeni of our services.
We also introduced the ELF Fello￿.$h1P Pr02ramme. a scheme desioned to suppon the recruiimeni and reieniion
of excellcni stsff working in Haemaiolo&N' SeTr'ices. The firsi FellO￿'ShIP wa5 a￿'arded to a nurse working on
Yartv Ward io undenak"e a master's deJ(y ee in Advanced Praclice Nursing.
Our fijndraisino team worked hard io deliver al)ove ihe income thrgei sei ai the sran of the year. We received
donations from a ranee of suppor(ers. includino trusts. local business. and indiN'iduals. Volunteers ran and cycled
for ELF. rdised moneN' by bucket collections at supemiarkets. completed Sky Dives and organised a range of
e￿entS from cream teas to quiz nigh15. Independent groups raised funds via well-anended events across the year.
We also received some siJu ificant donations from individuals remembering loved ones.
We did not receitr'e as much income from legac! giving as we have done in past vears. However. we began to
encourage future planned givino
through an inforniation campaign and M'cre pleased to receii'e 20 pledges from
supporters who intend io remember ELF in their Wills.
We extended the opening hours of Filling Time. our kiosk offering hot drinks and light refreshments to patients.
families and staff on the w'ard. We also recruited three volunieers io help deliver ihe service and provide cover
during periods of staff illness or holida).
Page 2

Exeter Leukaemia Fund CIO
Trustee5' Report (continued)
In November 2023. after an in-depth review. TThslees decided io close the ELF charitv shops. Althou?h the
shops madc a small profil. an increascd amounl of manageTnent time ￿'aS required. pushing the retail function
towards negative income. Sadly, this resulted in redundancies for four sthff. and affected the charity's turnover.
though ultimaiel!. allowed tnanaqemeni more time to focus on increasing income generation through fundraising
and expandino charitable services.
We coniinue io keep all services under re%"ieM" and seek new opportunilies to improve our support for patients.
We look fon4'ard to conlinuing to increase the number of patients M'e serve and expand the services we offer.
Molly Southwood
Chief Executive o￿lcer
Objective5 and actii'itie5
Policie5 and objectii'es
The objeciives of ELF. ￿.hICh are ouilined in ihe Consiiiuiion of the CIO dated l January 2014 are=
To promote and proiect the phN'sical and mental health of people suffering from leukaemia and related
diseases in the South West of Enoland (and particularli, Ihose living in Devon). and their relative5 and
loved one5. through ihe provision of financial assisiance. suppon. specialist equipment. education and
practical advice. whether to those people or to hospita15. clinics and hospices in Devon and
neighbouring counlies.
To advance the educaiion of the public in all areas relating io Leuk&emia and related diseases.
In setting objectives and planning for activities. the Trusiees and senior managemeni have given due
consideration 10 general guidance published bN' the Charity Commission relating to public benefit. including the
guidance 'Public benefit- runnino a charit). (PB?
Vision, Mission gnd Strglegy
Vision
We wani everv patient in Devon diagnosed with blood cancer to have the best PQS5ible outcome.
Mission Siatemeni
ELF'S mission is io creaie an environment where patients and iheir families are supporfed through their
leukaemia journe!.. We want lo ensure all blood cancer patients and their families have access to excellent
support seTh'ices, from the poini of diagrkQSiS to recovery and beN'ond.
Strategy
Working with our partners in the NHS. we will design and deliver sector-leading services to offer direct Support
to patieTrt5 and support the Haematology Centre at the Royal Devon & Exeter Hospital. which we helped to
build.
Page 3

F.xcter Leukaemia Fund CIO
Trustees, Report (continued)
Strategic Objectii'es
ELF Strategic Objectii'es 2024125
l. Service Developmeni
a. Increase current service delivery
b. North DeN'on and sites other than RDE
c. W'ellbeine Ser¥"ices
2. Preparing for future gromth
a. Marketing and brdnd awareness
b. Incotne oenerdtion. in particular legacies and grants
3. New HomelHub search and planning
4. Isolation Room Refurbishmenl
Objective I Sen'ice Development Building on success. auditing current reach and extending to new.
audiences
Our current service portfolio is focused on patients in Exeter. with limiled offers to places further afield. As
service users are added io the Clim. we have ihe opportuniN to audit where our current service users are. as
well as some demographic infomiaiion. and where the gaps might be.
Increase in service delivery. targets based on uplift from 231?4 perforn)ance.
i. Transport= 160 different patients driven across the year.
ii. Counselling.. 88 referrals. based on 6 session5 per person. Many people don'l use the full six sessions
50 ￿.¢ would c.1￿(1 to 5uppvn ¢wund 110 pcoplc.
iii. Support groups.. 20 patients acros5 M'o groups.
iv. Fellowships= We've awarded 3 this vear and would eX￿cl a similar number. based on I larger award
and ? smaller.
Paiietti Grants= Support for 24 patIen￿famIlies.
vi. Complemeniary Therapy= ?80 sessions. though many paiients have Enultiple sessions. so we expeci to
support around 150 people wilh ihis service. We are in the process of working with the therapisi. who
does noi use IT. to capture patient data in a secure way.
vii. Accommodation- Between l O and 20 patien￿'famIlIes.
viii. Filling Time.. 40-50 customers per day.
b. Nonh Devon and other sites
i. Work with Trusi ieam to understatjd various sites and what happens at each.
ii. Arranue visits to Sites io meet with siaff and patients.
iii. Promoie services accordinelv and idenlify areas ￿'here further resource will be needed.
Wellbeing Services
i. Audit counselling reach and consider audiences who aren t supported by current service provision.
li. Build new services in line with evidenced need.
Deliverables
Improved data retK)ning on services.
Actionable understanding of impacl on patients and families. (Q2)
C5ear. ￿Tillen Strate￿ for delivering existing services across Devon and Tn￿1 sites other then RD&E.
{Deadline: Q2)
Development plan for any gromqh or new services. including resourcing. (Deadline.. Q4)
Page 4

Eieter Leukaemia Fund CIO
Trustees, Report (continued)
Objeetlve 2 - Prepare for future gro*'th Diversifying and sustaining income stream5
The chariiy has relied on large le_2acies io fund operational aciivity. Generally. these have been realised.
However. there has noi been a dedicaied legacv fundraiser in the ieam since 2019. and the lack of a laroe legacy
in 20231?4 indicaies Ihe need to locus on ihis area. Additionallj. there is no dedicaied markeiing funciion to
raise brand a￿,areneSS. This year. we M'ill focus on improving our recognition locall), and across Devon. and also
cultivate legacy giving. We will additionallv develop a grant strategy based on clear cases for support.
a. Marketing and brand awareness
Invest siaff lime into awareness-rdi5ing locally (Exeter) and across Devon
ii. Reinforce messaging about hom. the charity is funded. especially legacy giving
iii. Develop tnarketing strategy in linc ￿'Ith emereing groM1h plans
iv. Develop conient based on impact of services on paiienTS
b. Income ueneration. in particular legacies and grants
CEO io lead on individual philanthropy. legacy cultivation and stewardship
ii. CEO and Developmeni Manager (Parnierships) io develop early grant application strategy. including
cascs for support and targe
iii. Focus on building more lucralive income streams. including third partv and corporate {Development
Manager. Comtnunity and Volun(eeringl
iv. Seek io appoini a third fundraiser in Q3. to build on high-performing income streams, anivor focus on
North Devon. wilh a view to delivering a budger surplus in ?025,'26.
Deliverdble5
Written marketin2 slrategry with identified targets and objectives (Deadline.. Q3)
Impaci-based conienl creaied {Deadline= Q2)
Trust and Grant applicaiion plan {Deadline: QI )
20 new leuacy pledge5 (Deadline.. Q4)
200/D increase on fvndraising income from 2023124 budget (Deadline: End Q4}
Objeetive 3 - New. HomelHub Planning and search for x 5uilable space to deliver Services and run the
charity
The charit) s activilies and managemeni are currently delivered from serval sites. primarily the RD&E hospital
and the Marsh Barton office. Several of the services we provide. particularly ￿e1]being services. cannoi be
delivered on our premises. Across the coming vear we will articulale the space we need to provide our services.
with room for growryh. and begin to seek appropriate premises.
Deliverables
Clearly articulated plan for space requirements. with room for growth (Deadline- Q2)
Markei research into resource required. corresEK)nding budget prepared (Deadline.. Q3)
Search begun for suiiable premises (Deadline: Q41
Objective 4 - Isolation Room Refurbishment
Working with the Yarry ieam. we have ideniified the need to repaini and redecorate the side rooms. or isolation
rooms. on Ihe ward. Workine with the Trust. we will fijndraise to complete the work5 for each room. to the
agreed standard. This objective is reliani on the TrusL and therefore deadlines will be in line wilh the iimescales
thev can work to￿.￿rds.
Page 5

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
Deliverables (deadlines to be confinned with RDUT team)
Work plan in place for each room
Fundraising target agreed
Funds secured.
Current Service Portfolio
The serYi¢es Exeter Leukaemia Fund currently offer in relation to the objectives are as follows..
Transport of patienls lo and from hospital
Counselling to help patients and families through the challenges of the illness
Financial support through our Patient Support Grnni scheme
Funds io purchase equipTnenl 10 improve patient treatment and suppon
Accommodation near the h05pithI so families can be close to their loved ones
Complementarv therapies for patients slaying on Yarry Ward
Free refreshments to patien15 and relatives awaiting Day C&se appointments
Financial advice through our partnership with the CAB
Legal services through our partnership with Dunn & Baker
Main activities undertxken to furth¢r the Charity's purposes for the public benefit
Services that ELF provided_for_2023124
Exetcr Leukaemia Fund {ELF) has coniinued to rebuild follow'ing ihe global pandemic of COVID-1g. The
charity, ha5 been revLe￿.1ng ihe ways in which services are provided and made changes necessary io ensure
econom}', etTicienc)' and effectivene5S.
Transport Service
The charil!. has ihree dedicaled drivers taking patients to and froTn iheir home to artend medical appointments at
the Haemaiology. Centre. In 202J14 the ELF ￿anSport team cotnpleied 1801 passenger journeys. With a total
disiance of 46.400 tniles.
This service is seen by exiernal agencie5 and partners as one of ELF'S Unique Selling Point (USP) services.
Counsellino SerN'ice
We appoinied a Counselling Service5 Lead to run the counselling service. which continues to grow. In 2023.Q4
104 patients were reFe￿¢d to ihe service and a tolal of 456 sessions were delivered. We also offered 5UPPOrt to
gmup work led bv the NHS.
Accommodation
ELF offers financial support io patients requiring holel stays in Exeter due to their treaimeni plans. We are
grateful to our partners at Mercure Souihgaie who offer a discounted rate for ELF patients.
Filin&Time
The ELF kiosk. in the Haematology Centre recepiion. offers snacks and refreshments io patients and their
supporters. A limited number of iiems. includine hot drink5. fruit. biscuits and crisps are offered free of charge.
though ma). users elect to ofTer a donation. The cafe is run by a member of ELF staff. and supported by
volunteer5 during periods ofannual leave or illnes5.
Page 6

Exeter Leukaemia Fund CIO
Trustees. Rcport (continued)
Complemenia
Therapies
Arotnatherapy massage treatment is provided for patients staying on Yatfy Ward. During the year. the service
offered ?3 I patient appointtnenls.
Ciiizens Advice Bureau Service
During the vear. ELF has continued to provide links lo the CAB service for patients requiring their specific help.
The CAB service provides assisthnce in a range of matters includittg emplowinent. housing. debt. benefits
advice. In 20? jJ•4 we were pleased to receive UFKlates from the CAB deiailing the support ihey were able io
provide. Thanks to their guidance. haematology paiicnts at the RD&E received a range of benefits and grants
totalling nearly half a million pounds.
. 4a1 Services
ELF offers a free will service (o pa(ienis. patients families. volunieers and 5UPPOrters through a partnership with
local soliciiors Dunn and Baker. The ser¥'ice includes Ihe MTriine of a standard w'ill and is complelelN' free of
charge. The swiich from a previous naiional supplier o(Yers a more localised personal service with a local otTice.
Achievements and performonce
2023124 Fundrdising O_bjectives
Improve donor retention by improving impaci and siewardship communicalion
Develop sustainable income streams. including legacy and regular giving
Develop trusts and grdnts siraiegi. io suppon specific projecLS
Improve fvndrdising processes to ensure m￿]muM etTiciency
Fundraisin
outcomes
Throu2h focused effort and an increase in the number of events the team were able to support. income was up
on the previous vear. The fi]ndraisino team had su¢¢ess in a number of areas. particularly Third Party giving and
events. and corporate giving.
Fundraising was supported by 94 volunieers contributing 510.5 hours of support. covering a range of roles such
as administration. bucket collections and coordinating collection boxes.
Due to increased activity in other areas. Trusts and Grants income was down on previous vears. though we did
receive SOTne uenerous donation5 in this area. In order to improve outcomes in the coming vear. the team
devoied lime io developing clear cases for suppon and researching grdni-making bodie5.
Retail
Following a challenging year with high sthff turnover and issues with the shop premises. the Trustees decided in
November 2023 to wind down Ihe chariN's retail function. The decision was taken after a comprehensive
review of income. possible alternaiives io closure. and the broader naiional picture for retail. The shop closures
resulted in four redundancies. which were managed in consulthtion th'iih the charitv's HR consultants. The
Exminsier shop closed in March ?024. and the Crediion shop is scheduled for closure in June ?024.
Review of activities
The Charl￿ s sthff and irusiees invested a significant amouni of time across the )'ear to reviewing process and
governance. This necessaTr' and comprehensive piece of work ensures that the charity is in the strongest possible
position to grow ihc future.
Page 7

Excter Leukaemia Fund CIO
Trustees, Report (continued)
The outlook is Yerv positive as we see a sirong response from our supporters. and a renewed partnership with
Yan!. Ward. We look forward lo M'orking M'ith staff. Trusiees and partners lo increase our service provision to
ensure the best possible ouicomes for haematology patients in Devon.
Financial review
Goingconcem
After making appropriate enquiries. the Trusiees have a reasonable expectation that the Chariw has adequate
resources io coniinue in operaiional existence for ihe foreseeable future. For ihis reason. Ihev coniinue io adopi
the 20ing concem basis in preparing the financial statements. Further details regarding the adoption of the going
concem basis can be found in the accounting policies.
Reserves
olic
The Irusiees, lon?_[e￿ strdieoN is to seek reserves excluding propertN' to provide financial stabilitv and the
means for the de&elopment of our principal activities. We iniend io Tnaintain our reserve5 at a level which Thould
allow an orderl!, ￿'Ind dO￿.n of ihe chariTh should thai ever need to be considered. In ihe coming vear we also
iniend io use a portion of our reserves io esthblish an invesmieni ponfolio with the aim of using interest realised
io contribuie ioM'ards charity running Costs. We intend to use the reserve5 in the following manner-
Financial suS￿lnabI]itV of the charity
Establishmeni of an investsneni portfolio
Communilv and Hospital Service developmeni
As at Ihe Year￿nd. ELF ha5 totsl funds available of £659.303 {2023 £71J.227) and unrestricted fi]nds of
£628.168 (?02J
£687.6581.
Structure. governance and managemenl
Constitution
Exeter Leukaemia Fund is a regislered charity. number 1154727. and is constituted under a Charity Commission
Scheme.
The ¢harity is governed by its CIO Deed. dated l January 2014 which was amended 19 Januarv 2021 and under
(his deed is consiiruied as a Charitable Incorpordted Organisalion (CIOI. The Trusiees meei quanerly. The CIO
deed stipulates that the Trustees shall comprise not more than ien. nor less than three persons.
The CIO has power io do an)thing which is calculated io further its objects or is conducive or incidentsl to
doing so. In particular. the CIO has power lo:
borrow money and to charee ihe whole or any part of its propenv as security for ihe rePa￿len1 of the
moneN borrowed. The CIO must comply as appropriaie with sections 124 and 125 of the Charities Act
201 l. if it Wi5hc5 to mortgage land:
buy. take on lease or in e.x¢hange. hire or othernise acquire any property and lo maintain and equip it
for use:
sell. lease or otherwise dispose of all or any part of the property belonging to the CIO. In exercising
this power. the CIO must comply a5 appropriate with sections 117 and 119-12J of the Charities Ac(
2011
emplov and remuneraie such stsff as are necessary for carrying out the work of the CIO. The CIO may
emploN' or remunerdte a chariTh' Irusiee onlN' to the eiieni ihai it is permilled io do so bN' clause 6
(Benefits and pa)Inents to charit), trustees and connecied persons) and provided it complies with the
conditions of that clause:
Page 8

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
deposit or inve51 funds. emplov a professional fund-manager. and arrange for the investment5 or other
propert). of the CIO io be held in the name of a nominee. ITr the same manner and subject 10 the same
onditions as the trusiees of a trust are pennitted to do bN' the Trustee Act 2000.
Membership of the CIO
The meTnbers of the CIO shall be its charity trustees for the time being. The only persons eligible to be
members of the CIO are its charity. tmsiees. Membership of the CIO cannot be transfe￿ed io anyone
else.
An). member and charity trustee who ceases io be a charity mistee automaiicallv ceases to be a member
of the CIO.
b. Methods of appoinunent or election of Trustees
The management of the Charity is the responsibility of ihe Trnsiees who are elecied and co-opied under the
iernis of the Charit! Commission Scheme. The Trustees are eligible. in committee. lo appoint additional trustees
under the tertns of the CIO consiitution.
Apart from the first charity trusiees. every Trustee may be appointed for a m&ximum tenn of ihrec. three-vear
iernis b!. a resolution passed at properl%" con%'ened meetings of the CIO Trustees. In selecting individuals for
appointment as Trusiees. the existino Trusiees must have regard to the skills. kno￿"ledge and experience needed
for the effective adrninistrdtion of the CIO.
c. Policie5 adopted for the induction and training of Trustees
New tru51ees are selected based on the skills that the), musl complemeni ihe existints Board of Trustees. They
mcei with cxis(in? Trust¢¢s and k¢v Member5 of staff to ensure that the!. fccl comfortablc with thc organisation
and happN' 10 become part of the team.
The charity Trustees will make available io each new charity Trustee. on or before his or her first appointmenl-
a) a copy of the current version of this constitution: and
b) a copy of the CIO'S Latest Trusiees, Annual Report and statement of accounts.
A5 W'ith all staff=
"The Trustees of ELF review salaries on an annual basis. normallN' Decembcr.. however. there is no guaraniee of
an auiomaiic increase in your paj. a5 a resuli of an), re¥'iew'"
Emplo)ee Handbook.
Plans for future periods
Page 9

Exetsr Leukaemia Fund CIO
Trustees, Report (contlnued)
The Tn￿CeS wlt I fo¢￿1 on the TElatiDnship with cl* RD & E. swificalty Yary WBrd and the wider baemathlogy
5erv%ce including that in North Ikvon. in Ordcr to proyide help and Sup[￿ to patsents in the most meanin￿] way.
This relation5kn"p is seen as pafdmount so thai th¢ Imematology 5t¥ff aTE SUPPOrted by the ¢lLafiry And can therefore
provid¢ th¢ best £ar¢ for their patients and so thdt ELF can provide support in ￿dItion to ihis care.
Th¢ T￿￿eS will also encour4g¢ chatity sthff io undert￿¢ a rryicw of patient Servi￿ ¢0 eJ)sure thry ¥re bping
manag¢d effectively arE fit for purtx)se Rnd the changing needs of the p8tienlS.
Funds held 25 CtsStodl*n
None
rt was approved by the tntsiecs ofthe cl4Tity on...... ... ...
. and signed on its behatf by:
VES
alomo
Page 10

Exeter ￿UkaeMia Fund CIO
Statement of Trustees, Responsibi]itles
The trw*es are responsible for preparing the mJsiet5' report and the financial siaieni¢nts in accordanre with the
UniTed Kingdom A¢¢ounting Swidards (Uniicd Ksngdom Gen¢rdlly Accepted Ac¢ounting Practic¢) and appli¢able
law and re8ulation&
The law applie&bl¢ to charities requires th¢ tru5tces to pr¢pwr Fin¥nciai Swetllents for ¢ach fllwicial year which
ve 2 bue and fair view of the stsre of affairs of the charity and of the incoming rcsources and application of
resources of the ¢lwity for thai pcriod. In PTep2ring these fuwicial sw¢ments, the trusice5 are required Ki:
select suitable accounling policies and apply then) ¢onsis(enlly'
observe the m¢tht¥ts principles in the Charities SORP.
mak¢ judgemcnts attd estimatrs that are reasonablc and prudeni
ststr whethcr applEcable accounting have b¢¢n followe& subject to any materia] departures dwloscd
and explained in the fttlanciai stsremeors: and
prepare the fiThancial stat¢￿¢llts on the goin￿ basis UDl¢ss il is inappmpriate (o pr&sumc tliai the charity
will contrT￿¢ in bu5inw.
The tru51ees are responsible for keeping proper accounting recorts that disclose with re&sonabl¢ accuracy ai arty
time the f￿￿1claI posiiion of th¢ charity ond enable th(m to ensure thc financial statements comply the
Charities Act 2011. th¢ Charities {Accowits 8nd Rq)QT(s) Regulations 2(M)8. 2nd the provisions of the consiitutioTL
The trustees are a]$0 T¢spoll5iblc for safe8uarth.ng thc akseLS of the chaTiry and hcnce for taking ￿asonable Steps fLFr
the prevenrion and detection of fraud and oih¢r irregularities.
The trust¢¢s are trsponstl)le for the mainEenance and integrily of the corporate aod financial Inforn￿tiOn ineludcd on
the cbAritable eompgnys websit¢. L¢8islation governin8 thc preparatsoi) alid di&sctninauon of financial ST4remenrs
rnay differ from legislatton in other Jurisdi￿0￿$.
Approved
s of the chgrity on ....
Signed on its bchalf by.
VESS
Chairman
Pagell

Exeter Leukacmia Fund CIO
Independent Examiner's Report to the trustees of Exeter Leukaemia Fund CIO
I report to the t￿Stee5 on mv examination of the accounts of Exeter Leukaemia Fund CIO for the year ended 31
March 2024.
Responsibilities and basis of report
As the charits. Irusiees of Exeter Leukaemia Fund CIO you are respoftsible for the preparation of the accounts in
accordance with ihe requirements of ihe Charities Act 2011 ('the Act,).
I repon in respeci of my examinaiion of the Exeier Leukaemia Fund CIO'S accounts carried oui under section
145 of the 201 l Act and in caryino out mv examinalion I have follo￿.ed all the applicable Directions given by
Ihe CharitK. Commission under section 145{5Mb) of the Act.
Independent examiner's st8tem¢nt
Sincc Exeter Leukaemia Fund CIO'S gross income exceeded £250.000 your examiner must be a member of a
bodN' listed in section 145 of the 2011 Aci. I confirni that l am qualified to undertake the examination because I
am a member of The Association of Chartered Certified Accountants. which is one of the listed bodies.
I have Compleled mv examination. I confirn) thai no maierial matters have come to my attention in connection
with the examination giving me Cause lo believe that in any maierial re5peci=
accountin? records were noi kept in respeci of Exeier Leukaernia Fund CIO as required by section 130 of
the Act: or
2. the accounts do noi accord with those records: or
3. the accounts do noi comply with the accouniing requirements concerning the fonn and content of accounts
set out in the Charities (Accounts and Repons) Regulations ?008 other than any requiremeni thai the
accounts give a 'true and fair view, which is not a maner considered as part of an independeni
examination.
I have no concerns and have come across no other matters in connection with the examinaiion io which anention
should be drawn in this report in order io enable a proper understhnding of the accounts to be reached.
Dave Tucker FCCA
Independent Examiner
The Association of Chanered Certified Accountants
Thompson Jenner LLP
Chartered Accountants
I Colleton Crescent
Exeter
Devon
EX2 4DG
Dale.. .%. i .Np4ernW £cz
Page 12

Exeter Leukaemia Fund CIO
Statement of Financial Actii'ities for the l'ear Ended 31 March 2024
Unreslrieled
runds
Rcslricled
funds
T(btal
?024
Note
Income ond Endowments from:
Donaiions and legacies
(hher irading activities
Investment income
?47.133
162.555
32.104
279.237
162.555
9.421
Total income
419.109
451 ?13
Expenditure on:
Raising fi]nds
Charitable activities
{?$0.527)
{*41.717)
1250.527)
•68.305)
(26.588)
Total expenditure
{49? ?44)
(?6.588)
1518.8i2)
Net (expenditurellincome
173.135)
5.516
{67.619)
Net movement in funds
(73.135)
5.516
{67.619)
Reconciliglion of funds
Total funds brought fonvtrd
687.658
25.619
713.277
Total fi]nds carried forward
20
614.5?3
31.135
645,658
The notes on pages 16 to 27 forTn an integrdl part of these financial statements.
Page 13

Exeter Leukaemia Fund CIO
Statemenl of Financial Actii'ities for the Year Ended 31 March 2024 {ciTrntinucd)
Lnre5trieted
funds
Restricted
funds
Total
2023
Note
Income and Endow'ments from:
Donations and legacies
Other trading aciivities
Investment income
294.139
137.522
i.909
24.951
319.090
137.522
Total income
435.570
460.5?1
Expenditure on:
Raising funds
Chariiable aciiviiies
1709.785)
745.777)
1209.785)
{249.JOO)
(3.5?3)
Tolal expenditure
{455.562)
(3.52Jl
{459.085)
Net (expenditure).'income
119.99?)
)1.428
1.436
Net movement in funds
(19.992)
1.436
Reconeiligtion of funds
Total funds brouJt forward
707.650
4.191
711.841
Total funds carried fonyard
20
687.658
)5.619
71J ?77
All of the charity's activities derive from continuing operntions durin? the above two periods.
The funds breakdown for 2023 is showTr in note 20.
The notes on pages 16 to 27 fom) an iniegrdl part of these financial S￿leMents.
Page 14

Exetsr Leukaemia Fund CIO
(Registration Dumber: 1154727)
Balance Sheet as at 31 March 2024
21124
2023
Nott
Flxed ￿Sets
Tan8ibl¢ 055ets
13
17,924
16.974
Current a$y¢ts
Stocks
Deb¢or5
Cash at bank in hand
14
2.627
41475
625.772
3.759
17,755
681,840
15
16
670,874
70J.354
CreditOf5: fallimg due Ivlthln one year
17
(43.140)
17,051)
Net Current assets
627.734
696.303
i et %%sets
645.658
713277
Funds of the th*r5ty:
R¢stri¢ted Income fund5
Restricied fiJn(Ls'
20
31.135
25.619
Unrestricted incoll￿ funds
Unrcstricted fijnds
614,523
687,658
Total lllnds
645.658
713,277
iLt
Thc fInan¢i￿ sralmnts on pagcs 16 to 30 approve4J by thc ond authoriscd for issue on ...... ...... .....
and Sly￿ed on th
haif by..
VESSa
Chairniall an
SE
The notes on pages 16 to 27 forn an integral pan of these financial statements.
Page 15

Eieter Leukaemia Fund CIO
'otes to the Financial Statements for the l'ear Ended 31 .March 2024
Charitv status
The charity is a Charitable Incorporated Organisation regisiered in England and Wales.
The address of its registered oiTi¢e is=
The ELF OtTice
HaemalologN Cenre
Ro)'al Devon & Eieter Hospithl
Exeier
EX2 5DW
2 Accounting policies
Statemenl of complianee
The financial staiements have been prepared IT7 accordance H'ith Aceountin? and Reporting by Charities=
Statement of Recommended Praciice (applicable lo Chariiies preparing their accounts in accordance with ihe
Financial ReportinLT Standard applicable in ihe UK and Republic of Ircland (FRS 1021) (issued in October 2019)
Ichariiies SORP (FRS 102)). the Financial Reporting Standard applicable in the UK and Republic of Ireland
(FRS I O?) and the Charities Act 2011.
Basis of preparation
Exeier Leukaemia Fund CIO meets ihe definition of a public benefii entitv under FRS 102. The accounts
(financial siaiementsl have been prepared under the historical cosi convention with item5 recogni5ed at cost or
transaction value unless othen¥ise sthied in the relevant noie{s) to ihese accounts.
Going concern
The trustees consider that there are no material uncertainties about the charity's abilit! lo continue as a going
concern.
Income and endowmen15
Voluntar), income includino
donations. 2ifts. leeacies and grants thai provide core funding or are of a general
nature 15 recognised when the charifv h&8 entiilemeni io the income. it is probable that the income will be
received and (he amouni can be measured with suificieni reliability.
Donaiion5 and legacies
Donations are recognised when the charity has been notified in ￿TIting of both the amount and Settlement date.
In the eveni that a donation is subject to conditions that require a level of perfomiat)ce b). the charity before the
charity is entitled io the funds. the income 15 defcrred and not recogni5ed until either those conditions are fully
met. or the fulfilmen( of those conditions is u.holly within ihe control of ihe charity. and il is probable thai these
conditions will be fulfilled in the reporting period.
Legacv gifts are recognised on a case by case basis followin? the grnni of probate when the
administrator.lexecutor for the estate ha5 communicated in MTiting both the amouni and sertlemeni dale. In the
eveni ihai the gift is in ihe forni of an asset other than cash or a financial asset traded on a recognised stock
exchange. recognition is subjeci io the fvalue of the gift being reliably measurable with a degree of reasonable
accurac￿. arkd the title to the asset havin2 been transferred io the charit%'.
Page 16

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 Nlarch 2024 (continued)
Granis receivable
Granis are reco£nised when the charitv has an entitlement to the funds and anv condition5 linked io the grants
have been met. Where perfonnance conditions are allached 10 the grant and are vei 10 be mei, the income is
recognised as a liabiliry and inclLEded on the balance sheet as deferred income to be released.
Gifls in k'ind
Gifts in kind donated for distribution are included ai valuaiion and recognised &8 income when they are
distributed io the projects. GifLs donaied for resale are included as income when the). are sold.
Gifl uid
Income tai recoverable in relation to donaiions received under gift aid or deeds of covenant is recognised at the
titne of the donation.
Inveslmenl income
Inieresi on fi￿d$ held on deposit is included when receivable and the amount can be measured reliably by the
charity- this is normall J. upon noiificaiion of ihe inieresi paid or pavable by (he bank.Dividends are recognised
once thc dividend has beeti declared and noiificaiion has been recei%ed of the dividend due.
Expenditure
All expenditure is recognised once there 15 a legal or construciive obligation to that expcnditurc. il is probable
settlemenl is required and ihe amoun( can be measured reliabl¥. All costs are allocaied io the applicable
eipendiiure heading thai a￿re0ate similar c051s to that category. W'here costs cannot be directly attributed to
particular headings they have been allocaied on a basis consisieni M'iih the use of resources. ￿1th Cen￿al staff
costs allocaied on the basis of time spenL and deprecialion charges allocated on the portion of the asset's use.
Other support costs are allocated based on the sprcad of staff costs.
Raisingfunds
These are costs incurred in attrdcling voluniary income, the management of investments and those incurred in
trading activities thai raise funds.
Charilable actlF'ilie
Charitable expenditure comprises those costs inCu￿ed by the charity in the delivery of its acti￿11]eS and services
for its beneficiaries. It includes boih costs ihai can be allocaied directly to such aciivilies and those costs of an
indirect nature necessatTr' io suppon them.
Support costs
Support costs include Centrdl fimclions and have been allocated to aclivity cost calegories on a basis consisteni
with the use of resources. for example. allocating property costs by fl￿r area5. or per ¢apit& staff costs by the
time spent and other costs by their usage.
GoN'ernance costs
"rhese include ihe costs attribulable to the charity's compliance with constitutional and statutory requirements.
including audit. strategic management and trustees meelings and reimbursed expenses.
Page 17

Eieter Leukacmia Fund CIO
Notes to the Financial Stalements for the Year Ended 31 March 2024 (continued)
Taxatio
The chariti, is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act 2010 and
therefore it meets the definition of a charitable compan). for UK corpordtion t&K purpose5. Accordingly. the
chariTh' is potentially exeTllPi from ￿latiOn in respect of income or capital oains received within categories
covered b￿. Chapter J Part I l of (he Corporation TLX Act ?010 or Section 256 of the Taxation of Charoeable
Gains Act 1999 io the exteni that such income or ghins are applied exclusivelv lo charitable purposes.
T9ngible fixed a55els
Individual fi.xed assets costing £ 100.00 or more are initiall! recorded ai cosL less any subsequent accumulated
depreciation and subsequent accumulated impaimlent losses
Depreeiation and amorlisglion
Depreciaiion is provided on tangible fixed assets so as to write off the cosi or valuation. less any estimated
residual value. over their expecied useful economic life &5 follows..
-4sset class
Motor vehicles
Fixture5 and fittings
oirice equipment
Depreciation method and rate
?0 /0 strdight line
1511/0 straight line
200/0 and 33.330/0 Straight line
Stock
tock is valiied at the lower nf cnst and estimated selling price less costs io complete and sell. after due regard
for ob501ete and slow moving stocks. Cost is determined usin£ the first-in. first-oui {FIFO).
Trade (lebiors
Trade dLbtors are amowits due from customers for merchandise sold or ￿rVIceS perforn)ed in the ordinary
course of busines5.
Trade debtor5 are recognised initiall). ai the transaction price. TheN' are subsequentlv measured at amortised cosi
usino the effective inierest meihod. less provision for impairment. A provision for the impaimient of trade
debtor5 is esiablished when there is objective evidence that the eharitv will not be able io colleci all amounts due
according to the original lemis of the receivables.
Cash and cash equil'alents
Cash and cash equii'alcnts comprise cash on hand and call deposits. and other shon-lerni highly liquid
investments that are readil!, convertible io a known amouni of cash and are subjecl to an insignificant risk of
chanoe in value.
Trade creditors
Trade creditors are obljtialioTts to pav for 200ds or services thal have been acquired in the ordinary course of
business from suppliers. Accounts pavable are classified as curretti liabilities if the does not have an
unconditional righi. ai the end of the reporting period. to defer sertlemenl of the creditor for at least twelvc
month5 after the reportinq da(e. If there is an unconditional riuthi io defer settlemeni for ai le8sl twelve months
after the reponing dale. thev are presented as non-current liabilities.
Trdde creditors are recognised initially at the trdnsaciion price and subsequently measured at amortised cosi
usino the effective interest tnethod.
Page 18

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2024 (continued)
Fund structure
UnrestrictLd income funds are general fund5 that are available for use at the trustees discretion in furtherdnce of
che objecrives of the charl￿.
Restricted incotne funds are those donated for use in a particular area or for specific purposes. the use of which
is resiricied lo that area or purpose.
Pensions and other post retirement obligations
The charit). operares a delined contribuiion pension ￿herne which is a pension plan under which fixed
contributions are paid inlo a pension fund and the charity has no legal or constructive obligation to pav further
contributions even if the fund does not hold sufricient assets io pay all employees the benefits relating to
emplovee service in the CU￿ent and prior peri(Kls.
Contributions to defined contribulion plans are recognised in the Statement of Financial Activities when they are
due. If contribution payments exceed the contribution due for service. the excess is reco?nised as a prepa￿)ent.
Financial instruments
Thc Charits. onl! ha5 financial assets and financial liabilities of a kind that qualify &5 basic financial InSt￿ments.
Basic financial instruments are iniliallN' recognised ai transaciion price and subsequently measured at their
senlemeni value wilh ihe exception of bank loans which are subsequenily measured at amonised cosi using the
effective interest method.
Page 19

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year F.nded 31 March 2024 (continued)
3 Income from donations and le%acies
Unrestricted
funds
General
Resiricted
funds
Total
2024
Total
2023
Donarions and legacies-
Donations from companies. trusts
and similar proceeds
Legacies
Grants, including capital grants-
Grants from companies
21 i.9(vl
25.519
20.854
2J4.818
25.519
207.984
92,061
7.650
18.900
19.045
247.133
32.104
279.237
4 Income from other trading activities
L.nre51ricted
funds
General
Total
funds
Total
2023
Trading income-
Ch¢irits' 5hop5
Other fundraising
1 ?9.310
1 ?9.3?0
114.805
2?.717
162.555
162.555
l J7.522
5 Investment income
Unrestricted
funds
General
Total
2024
Total
2023
Dividends receivable from other listed investments
Interest receivable on bank deposits
133
9.288
133
237
3.672
9.4?1
9.421
3.909
Page 20

Tr".xclcr Leuk#L'mia Tr und (.'1()
Notes to thL' Financial St#tement% fi)r IhL' Yc'ar b:n(IL.d .11 Miirl'h 2024 {continued}
6 b.xpeiidiliirL' on chxrilahlc Activities
C'(Isl ur
rai%inx fun(1
'I'inie
.4upporl
upport
C'uunselling -fr#nsporl
f¥upport
2024 -fotAI
2023 'folul
Si£ifT Los15
l)eprLcialion
l()%pilal LquipniLiit
Purchases
Reni dnd rates
Office costs
-rravL.l and SLib5iStL'nce
11- and comiiiUI)ILalions
RLpairs aiid maiiilLiiaiice
.1 r1( n5POrt
Profe55ional fees
Other
Support g>ranls
(l)rLTrfill/l.oss on disposal
(i()venianLe cosls
129.987
919
14,1470
8,149
64,Y42
2,1192
-i.f .825
1.527
2$3.771
6.gY¥
183
226,13.3
183
20.447
11.624
32.428
13,123
1.77X
12.1184
2.0021
36.272
19,929
44.528
8.000
7.1
24.486
16.832
27,636
15,234
1,757
7.603
18.407
2,740
19,572
34,024
18,573
4.879
6,388
2,951
579
5.170
53
33
156
2,144
264
77
4?.1
1,06%
531
1.810
75
25.003
3.391
488
19.608
25.003
14,658
45,705
15,049
147
2,709
11,229
20
19
202
384
22.830
7,952
3.208
2.766
5,165
15,049
124
23
44.859
44,85Y
2.32.437
18.090
20,561
18.089
-3.067
1 8.089
23,1.30
18,0¥9
99.1172
18.08Y
108.-f35
(108.535)
518,832
4.59.08.S
Supp()rt costs
Total expenditure 2024
111.089
250.527
38,6.50
21,156
41,219
50,119
518,832
459.08.5
l olal expenditure 2023
209.785
27.333
37.785
27,36Y
32,574
124,239
459,085
PagiL 21

Eieter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2024 (continued)
Of lolal expenditure £26.588 (2023 - £3.523) is restricted and £492.244 (2023 - £455.562) 15 unrestricted.
7 Anali'sis ofgovernance and support costs
Governance costs
Llnrestricled
funds
General
Total
?024
Total
2023
Staff costs
Wages and salaries
Social security COSL8
Pension costs
Independeni examiner fees
Examinaiion of the financial sthiemen
Other fees paid 10 examiners
37.159
3.787
913
37.159
3.787
913
19.122
2.061
468
1.000
2.000
.000
2.000
945
1.890
44.859
44.859
24.486
8 Net incomingloulgoing resources
Nei {ouigoing)lincoming resources for the year include-.
2024
2023
{Profit)Iloss on disposal of fixed assets
Depreciation of fixed assets
147
6.998
73
5.37?
9 Trustees remuneration and expenses
No trustees. nor any persons connecied with them. have received any remunerdtiork from the charity during the
year.
No trustees have received any reimbursed expenses or any oiher benefits from the charity during the year.
Page 22

Exeter Leukaemia Fund CIO
Yotes to the Financial Statements for the Year Ended 31 March 2024 (continued)
l O Costs
'I'he aggre?aie payroll costs were as follows-
2024
2023
Staff costs during the vear were:
Wages and salarics
Social securi￿. cos
Pension costs
274.464
16.07?
5.096
229.719
13.528
4.536
?47.783
The monthly average number of person5 (including senior management / leadership team) employed by the
chariN durino the vear was as follows:
2024
2023
Average number of emplovees
14
12
Contributions 10 the employee pension schemes for the year totalled £5.096 (2023 - £4.536).
The total employee benefits of the key manaoement personnel of the charity were £83.718 (2023 - £65.061).
No employee re¢eived emoluments of more than £60.000 during the vear
I I Independent examiner'5 remunergtion
2024
2023
Examinaiion of the financial statements
1.000
945
Other fee5 to exaTniner5
All oiher services
2.000
1.890
12 Taxation
The charity is a regisTered charity and is therefore exempi from raxaiion.
Page 23

Eieter Leuk#emia Fund CIO
Note5 to the Financial Statements for the Year Ended 31 March 2024 (continued)
13 Tangible fixed assets
Furniture and
equipment
Computer
equipment
Moior Trehicles
Total
Cost
At l Apri5 2023
Additions
Disposals
4.483
11.973
18.581
8.095
35.037
8.095
(J,511)
At J l March 2024
Depreciation
At l April ?023
Charge for the year
Eliminated on disposals
3.814
219
3.991
2.395
10.258
4.384
{J.J641
18,063
6,998
{3.J64}
At 31 March 20?4
4.033
6.386
Net book value
Ai J l March 20?4
450
5.587
11.887
17.924
Ai J l March 2023
669
7.982
8.3?3
16.974
14 Stock
20?4
2023
Stocks
3.759
15 Debtors
2024
2023
Trade debtor5
Prepaj'ments
VAT recoverable
Other debtors
4.093
8.465
2.565
27.35?
2.597
10,025
1.891
17.755
16 Cash and cash equii'alents
2024
2023
Cash on hand
Cash at bank
i42
681.498
6?5.499
625.772
681.840
Page 24

F.xeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 Marcb 2024 (continued)
17 Creditors: amounts fallin2 due wtthin one !'e2r
2024
2023
Trade creditors
Other taxation and social security
Other creditors
Accruals
9,565
149
950
1.682
4.270
1,377
i2.198
4i.140
7,051
18 Contingent assets
Legaev Income
As at 31 March 2024. the charity had been notified of one residuary legacy the value of which is uncertain as the
exe¢utor 15 awaiting confimation of other claims on the estate. but il is unlikely io exceed £34.?75. As ai the
date of approval no further inforn]ation had been received and so this legacy has not been accrued.
19 Ohliggtions under leases and hire purehise contracts
Operatine lease Commitments
Total future minimum lease payments under non-cancellkble opernting le2ses are as follows".
20?4
2023
Other
Within one vear
Between one and five years
i8.601
19.961
46.955
53.350
58.562
I00.J05
Page 25

Exeter Leukaemia Fund CIO
otes to the Financial Statemenls for the Year Ended 31 March 2024 (continued)
20 Funds
Balance al
.4pril 2023
Incoming
resources
Re50urce5
expended
Balance at 31
Mgrch 2024
Unre51ricted funds
General
General funds
687.658
419.109
{492 ?44)
614.523
Restricted funds
Chei'iihornc Famil). Suite
Counsellor
Transport
Hospital fund
Patient support (coordinator)
Fellowship
668
668
7,250
10.250
.000
16.729
.000
(3.000)
( 1.000)
(5.917)
(15.5841
(1.087)
1.830
23.121
12.642
8.537
2.038
Total restricted fund5
25.619
(96.5881
31.135
Total funds
713.277
451,213
(518.832)
645.658
Bal#nee at I
April ?0?2
Incoming
rt50urce5
Resources
eipended
Balanceal 31
.March 2023
Unrestricted funds
Generul
General fimds
707.650
435.570
{455.562)
687.658
Restricted
Chei'ithorne Family Suite
Coun5ellor
Transport
Patient Support {Hard5hip Fund)
Hospital fund
Paiicnl support (coordinator)
873
2.270
48
(205)
(2.270)
(481
( 1.000)
668
1.830
?3.121
1.830
23.121
Total restricted funds
4.191
?4.951
li.5?3)
?5.619
Total funds
711.841
460.521
(459.085)
713,277
Page 26

Exeter Leukaemia Fund CIO
Tlotes to the Financial Statements for the Year Ended 31 March 2024 (continued)
The specific purposes for which the funds are io be applied are as follows:
Chevithorne Familv Suile
The resiricied funds represent amounts received for the Cheviihorne project. The
project is complete and Ehe balance caThied fonvard is io pay for the upkeep of the suite. There has not been any
spend on thi5 project in ihe l'ear.
Counselling - Granis received to cover counselling statTing costs.
Trdnspon - Income has been received in the period to help supwyrt the transpon service.
Patient Support {Hard5hip Fund) - Donalions of £l.000 received in the previous financial year to help ￿nd
paiieni support which was speni in the prior vear.
Hospital fund - This fund represents any income received which is resiricied to expenditure on Hospi(al support.
Patient Support Coordina(or - This fund represents amounts rni5ed from a campaign thai was run in order to
fund the coordinator position.
Fellowship - Thi5 fund represents any income received which is res￿]cted to the fellow'ship proerdmme.
21 Analvsi5 of net gssets between fvnds
Unrestricted
funds
General
Total funds at
31 March
2024
Re51ricted
funds
Taftgible fixed assets
Current assets
Current liabilities
17.924
639.7J9
{4J.140)
17.924
670.874
{43.140)
31.135
Total nei assets
614.52i
645.658
Unrestricted
funds
General
Total funds at
31 March
2023
Restricted
funds
Tangible fixed assets
Current assets
Current liabilities
16.974
677.73$
17.051)
16.974
70J.354
{7.051)
25.619
Total nei assets
687.658
713.277
22 Related partv transaetions
TheiL wL'ie no related pam Msactions in the vear.
Page 27